Webinars launched to improve first downloadable artificial pancreas app usage
A series of webinars are being held to help people with diabetes and healthcare professionals learn how to use the world’s first downloadable artificial pancreas app.
The CamAPS FX app, developed by diabetes researcher Professor Roman Hovorka, works with an insulin pump and a glucose monitor to automatically deliver insulin to people with this life-threatening condition via a complex algorithm.
The first online session entitled ‘CamAPS FX Webinar 1: introducing the closed-loop insulin delivery system’ will take place on Wednesday, October 7 at 630pm.
“Our aim is to alleviate the ever-present burden of type 1 diabetes and improve health outcomes. This is the outcome of hard work, with more to come. We are indebted to all who are helping us on this journey Professor Roman Hovorka
The virtual sessions will focus on introducing the closed-loop insulin delivery system and how it works and will be delivered by diabetes specialist clinicians.
Currently, people with type 1 diabetes rely on a routine of finger-prick blood tests and insulin injections or infusions just to stay alive, because their pancreas no longer produces insulin itself.
The app – which Professor Hovorka hopes will become available in the future on the NHS – will take over much of the management of the condition. This is particularly important at night, when many people with type 1 diabetes experience potentially dangerous low blood glucose levels.
The app can also upload the user’s blood glucose measurements seamlessly to Diasend, an online platform, allowing their diabetes team to provide more personalised care.
The CamAPS FX app is backed by 13 years of clinical research carried out by Professor Hovorka and his research group.
It is licensed for use by both adults and children with the condition – including pregnant women, and children aged one and up.
It is the first artificial pancreas system to be licensed for use in pregnancy, or by young children. The app is now available for UK users to download onto Android phones via the Amazon Appstore and costs £70 a month on a subscription basis.
The CamAPS FX app is a first step towards a fully automated and interoperable artificial pancreas.
Fully automated and interoperable artificial pancreas technology will fundamentally change life with type 1 diabetes, by working with a range of insulin pumps and glucose monitors to lift the burden of managing a condition that is relentlessly unpredictable day and night.
Professor Hovorka will continue refining the artificial pancreas through research into mealtime glucose control and improving ease of use.
Professor Hovorka, Professor of Metabolic Technology at the University of Cambridge, said: “This is a major stepping stone towards providing widely available, clinically proven, and user friendly artificial pancreas technology to people with type 1 diabetes.
“Our aim is to alleviate the ever-present burden of type 1 diabetes and improve health outcomes. This is the outcome of hard work, with more to come. We are indebted to all who are helping us on this journey.”
To register and reserve your place, click here.